¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"excitatory presynaptic fiber"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® muscle cell(=muscle fiber) ÇÑ±Û ±ÙÀ°¼¼Æ÷
¼³¸í   
  ±ÙÀ°Àº ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁö¸ç, ±ÙÀ°¼¼Æ÷ÀÇ ¸ð¾çÀº ´ÙÀ½°ú °°´Ù(¼öÀDZÙ, ºÒ¼öÀDZ٠¿Ü¿¡ ½ÉÀå¿¡ Àִ ½ÉÀå±ÙÀº ºÒ¼öÀDZٿ¡ ÇØ´çÇÏÁö¸¸ ±× ¸ð¾çÀº ¼öÀDZٰú °°¾Æ µû·Î ºÐ·ùÇÑ´Ù).
  
  ±ÙÀ°¼¼Æ÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitatory presynaptic fiber
    ÈïºÐ½Ã³À½ºÀÌÀü¼¶À¯, ÈïºÐ¿¬Á¢ÀÌÀü¼¶À¯
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • presynaptic
    ½Ã³À½ºÀÌÀü-, ¿¬Á¢ÀÌÀü-
  • presynaptic facilitation
    ½Ã³À½ºÀÌÀüÃËÁø, ¿¬Á¢ÀÌÀüÃËÁø
  • presynaptic inhibition
    ½Ã³À½ºÀÌÀü¾ïÁ¦, ¿¬Á¢ÀÌÀü¾ïÁ¦
  • presynaptic membrane
    ½Ã³À½ºÀÌÀü¸·, ¿¬Á¢ÀÌÀü¸·
  • presynaptic terminal
    ½Ã³À½ºÀÌÀüÁ¾¸», ¿¬Á¢ÀÌÀüÁ¾¸»
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
  • excitatory
    ÈïºÐ-
  • excitatory junctional potential
    ÈïºÐÁ¢ÇÕºÎÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ½Ã³À½ºÀÌÈÄÀüÀ§, ÈïºÐ¿¬Á¢ÀÌÈÄÀüÀ§
  • excitatory synapse
    ÈïºÐ½Ã³À½º, ÈïºÐ¿¬Á¢
  • excitatory transmitter
    ÈïºÐÀü´Þ¹°Áú
  • local excitatory state
    ±¹¼ÒÈïºÐ»óÅÂ
  • subliminal excitatory process
    ¹®ÅιØÈïºÐ°úÁ¤
  • annular reticular fiber
    °í¸®±×¹°¼¶À¯
  • apical fiber
    »Ñ¸®³¡¼¶À¯, ±Ù÷¼¶À¯
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fiber
    ¼¶À¯
  • afferent nerve fiber
    µé½Å°æ¼¶À¯
  • nerve fiber
    ½Å°æ¼¶À¯
  • parallel fiber
    ÆòÇ༶À¯
  • postganglionic nerve fiber
    ½Å°æÀýÀÌÈļ¶À¯
  • preganglionic nerve fiber
    ½Å°æÀýÀÌÀü¼¶À¯
  • Purkinje fiber
    ½ÉÀåÀüµµ±ÙÀ°¼¶À¯, Ǫ¸£Å°´Ï¿¡¼¶À¯
  • red muscle fiber
    Àû»ö±ÙÀ°¼¶À¯, Àû»ö±ÙÀ°¼¼Æ÷
  • reticular fiber
    ±×¹°¼¶À¯, ¸Á»ó¼¶À¯
  • smooth muscle fiber
    ¹Î¹«´Ì±ÙÀ°¼¶À¯, ¹Î¹«´Ì±ÙÀ°¼¼Æ÷
  • unmyelinated fiber
    ¹Î¸»ÀÌÁý½Å°æ¼¶À¯
  • white muscle fiber
    ¹é»ö±ÙÀ°¼¶À¯, ¹é»ö±ÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitatory presynaptic fiber
    ÈïºÐ¿¬Á¢ÀÌÀü¼¶À¯
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • presynaptic facilitation
    ¿¬Á¢Àü¼ÒÅë
  • presynaptic inhibition
    ¿¬Á¢Àü¾ïÁ¦, ½Ã³À½ºÀü¾ïÁ¦
  • presynaptic membrane
    ¿¬Á¢Àü¸·
  • presynaptic
    ¿¬Á¢Àü-, ½Ã³À½ºÀü-
  • presynaptic terminal
    ¿¬Á¢ÀüÁ¾¸»
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
  • excitatory
    ÈïºÐ-
  • excitatory synapse
    ÈïºÐ¿¬Á¢
  • excitatory transmitter
    ÈïºÐÀü´Þ¹°
  • excitatory junctional potential
    ÈïºÐÁ¢ÇÕºÎÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ½Ã³À½ºÈÄÀüÀ§, ÈïºÐ¿¬Á¢ÈÄÀüÀ§
  • local excitatory state
    ±¹¼ÒÈïºÐ»óÅÂ
  • subliminal excitatory process
    ¿ªÇÏÈïºÐ°úÁ¤
  • A-delta fiber
    ¿¡À̵¨Å¸½Å°æ¼¶À¯
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼¶À¯
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • presynaptic fiber
    ½Ã³³½ºÀü¼¶À¯(¡­àéë«).
  • EPSP (excitatory postsynaptic potential)
    ÈïºÐ¼º(ýéÝÇàõ)½Ã³³½ºÈÄ(ý­)ÀüÀ§(ï³êÈ), ÈïºÐ¼º ¿¬Á¢(Ö§ïÈ)ÀüÀ§
  • Fast EPSP (excitatory postsynaptic potentials)
    ±Þ¼Ó(ÐááÜ)½Ã³À½ºÈÄ(ý­)ÀüÀ§Â÷(ï³êÈó¬)
  • Fast excitatory postsynaptic potentials (EPSP)
    ±Þ¼Ó(ÐááÜ)½Ã³À½ºÈÄ(ý­)ÀüÀ§Â÷(ï³êÈó¬)
  • presynaptic
    ½Ã³³½ºÀü(ÀÇ).
  • presynaptic density
    ¿¬Á¢ÀÌÀüÄ¡¹ÐÁú
  • presynaptic facilitation
    ½Ã³³½ºÀü(ºÎ)¼ÒÅë(¡­îñÝ»áÂ÷×).
  • presynaptic inhibition
    ½Ã³³½ºÀü¾ïÁ¦ (¡­åäð¤).
  • presynaptic inhibition
    ½Å°æÁ¢ÇÕÀü ¾ïÁ¦
  • presynaptic membrane
    ½Ã³³½ºÀü(ºÎ)¸· (¡­Ø¯).
  • presynaptic membrane
    ¿¬Á¢ÀÌÀü¸·
  • presynaptic membrane
    ½Ã³³½ºÀü(ºÎ)¸· (¡­Ø¯).
  • presynaptic part
    ¿¬Á¢ÀÌÀüºÎºÐ
  • presynaptic potential
    ½Ã³³½ºÀüÀüÀ§.
  • presynaptic receptors
    ½Å°æÁ¢ÇÕÀü ¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitatory presynaptic fiber
    ÈïºÐ¼º ½Ã³³½ºÀü ¼¶À¯(¡­îñàéë«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • presynaptic fiber
    ½Ã³³½ºÀü¼¶À¯(¡­àéë«).
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ(¡­ýéÝÇßÒ÷¾).
  • central excitatory state
    ÁßÃß¼º ÈïºÐ»óÅ£¨£þýéÝÇßÒ÷¾£©
  • excitatory
    ÈïºÐ¼º(ýéÝÇàõ)ÀÇ.
  • excitatory amino acid
    ÈïºÐ¼º ¾Æ¹Ì³ë»ê
  • excitatory junctional potential =EJP
    ÈïºÐ¼º Á¢ÇպΠÀüÀ§(ýéÝÇàõïÈùêÝ» ï³êÈ).
  • excitatory postsynaptic potential
    ÈïºÐ¼º½Ã³À½ºÈÄÀüÀ§(ýéÝÇàõ~ý­ï³êÈ)
  • excitatory postsynaptic potential =EPSP
    ÈïºÐ¼º ½Ã³³½ºÈÄ ÀüÀ§(¡­ý­àéë«).
  • excitatory synapse
    ÈïºÐ¼º ½Ã³³½º.
  • excitatory transmitter
    ÈïºÐ¼º Àü´Þ¹°Áú(¡­îîÓ¹Úªòõ).
  • excitatory transmitter
    ÈïºÐ¼ºÀü´Þ¹°Áú(ýéÝÇàõîîÓ¹Úªòõ)
  • local excitatory state
    ±¹¼ÒÈïºÐ»óÅÂ(¡­ßÒ÷¾).
  • subliminal excitatory process
    ¿ªÇÏÈïºÐ°úÁ¤(Ú¿ù»ýéÝÇΦïï).
  • ascending nerve fiber, climbing fiber
    ¿À¸§¼¶À¯
  • perforating fiber [sharpeys fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Presynaptic membrane
    ¿¬Á¢ÀÌÀü¸·
    [¿¾ ¿ë¾î] ¿¬Á¢Àü¸·
  • Presynaptic part
    ¿¬Á¢ÀÌÀüºÎºÐ
    [¿¾ ¿ë¾î] ¿¬Á¢ÀüºÎ
  • Presynaptic vesicle
    ¿¬Á¢ÀÌÀü¼ÒÆ÷
    [¿¾ ¿ë¾î] Àü¿¬Á¢¼ÒÆ÷
  • Presynaptic density
    ¿¬Á¢ÀÌÀüÄ¡¹ÐÁú
    [¿¾ ¿ë¾î] Àü¿¬Á¢Ä¡¹ÐÁú
  • Perforating fiber [Sharpey`s fiber]
    ½Ã¸àÆ®Áú°üÅë¼¶À¯
    [¿¾ ¿ë¾î] ½Ã¸àÆ®Áú°üÅë¼¶À¯
  • Ascending nerve fiber, Climbing fiber
    ¿À¸§¼¶À¯
    [¿¾ ¿ë¾î] »óÇà½Å°æ¼¶À¯
  • Perforating fiber
    °üÅë¼¶À¯
    [¿¾ ¿ë¾î] °üÅë¼¶À¯
  • Muscle fiber
    ±ÙÀ°¼¶À¯
    [¿¾ ¿ë¾î] ±Ù¼¶À¯
  • Spiral fiber
    ³ª¼±½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ³ª¼±½Å°æ¼¶À¯
  • Anular reticular fiber
    µ¹¸²¼¼¸Á¼¶À¯
    [¿¾ ¿ë¾î] À±»ó¼¼¸Á¼¶À¯
  • Afferent nerve fiber
    µé½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¼öÀԽŰ漶À¯
  • Zonular fiber
    ¶ì¼¶À¯
    [¿¾ ¿ë¾î] ¼Ò´ë¼¶À¯
  • Myelinated nerve fiber
    ¸»ÀÌÁý½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] À¯¼ö½Å°æ¼¶À¯
  • Gustatory nerve fiber
    ¹Ì°¢½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¹Ì·Ú½Å°æ¼¶À¯
  • Nonmyelinated nerve fiber
    ¹Î¸»ÀÌÁý½Å°æ¼¶À¯
    [¿¾ ¿ë¾î] ¹«¼ö½Å°æ¼¶À¯
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dietary fiber
    ½ÄÀ̼¶À¯(ãÝìÈàéë«)
  • excitatory autacoid
    ÈïºÐ¼º(ýéÝÇàõ) ¿ÀŸÄÚÀ̵å
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • presynaptic
    ½Ã³³½ºÀü(ÀÇ)
  • fiber
    ¼¶À¯
  • fiber distributed data interface(FDDI)
    ±¤³×Æ®¿öÅ©
  • longitudinal fiber
    ¼¼·Î¼¶À¯, Á¾ÁÖ¼¶À¯
  • motor fiber
    ¿îµ¿(½Å°æ)¼¶À¯
  • muscle fiber
    ±Ù¼¶À¯
  • purkinje's fiber
    ǮŲ¿¹¼¶À¯
  • radial fiber
    ºÎä»ì¼¶À¯, ¹æ»ç¼¶À¯
  • reticular fiber
    ¼¼¸Á¼¶À¯
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LES Lambert-Eaton syndrome; Lawrence Experimental Station [agar]; local excitatory state; Locke egg seru...
EPSP Excitatory Post-Synaptic Potential; ÈïºÐ¼º ½Ã³À½ºÈÄ ÀüÀ§
CES carboxylesterase; cauda equina syndrome; cat's eye syndrome; central excitatory state; chronic elect...
EAA electroacupuncture analgesia; Epilepsy Association of America; essential amino acid; excitatory amin...
EAAC excitatory amino acid carrier
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PSD Presynaptic dendrites
EAA Excitatory Amino acid
EAAR Excitatory amino acid receptor
EAAT excitatory amino acid transporter
EAAC1 Excitatory amino-acid carrier 1
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • presynaptic fiber
    ½Ã³³½ºÀü ¼¶À¯
  • presynaptic
    ½Ã³³½ºÀüÀÇ
    ½Ã³À½ºÀÇ ±ÙÀ§ºÎ¿¡ ÀÖ´Â. ½Ã³À½º°¡ ±³Â÷Çϱâ Àü¿¡ ÀϾ´Â.
  • presynaptic inhibitory action
    ½Ã³³½ºÀü ¾ïÁ¦ ÀÛ¿ë
  • presynaptic potential
    ½Ã³³½ºÀü ÀüÀ§
  • central excitatory state
    ÁßÃß ÈïºÐ »óÅÂ
  • excitatory component
    ÈïºÐ ¿ä¼Ò
  • excitatory input
    ÈïºÐ¼º ÀÔ·Â
  • excitatory junctional potential
    ÈïºÐ¼º Á¢ÇպΠÀüÀ§
  • excitatory postsynaptic potential
    ÈïºÐ¼º ½Ã³³½º ÈÄ ÀüÀ§
    ¾Æ¼¼Æ¿Äݸ°À̳ª ±Û·çŸ¸ÞÀÌÆ®¿Í °°Àº ¹°Áú¿¡ Ȱ¼ºÈ­µÇ´Â ¾î¶² À̿ Åë·Î¸¦ ÅëÇØ ƯÁ¤ ÀÌ¿ÂÀÌ À¯ÀÔµÇ¾î ½Ã³À½º ÈO÷ÀÇ ¸·Àü¾ÐÀ» Å»ºÐ±Ø½Ã۰í, ±× °á°ú ¸·Àü¾ÐÀÌ ¿ªÄ¡¿¡ µµ´ÞÇÏ¿© ½Ã³À½ºÈÄ ¼¼Æ÷¿¡ Ȱµ¿ Àü¾ÐÀÌ »ý¼ºµÉ ¶§ ¿ªÄ¡¿¡ µµ´ÞÇϱ⠽±µµ·Ï ¸·Àü¾ÐÀ» Å»ºÐ±Ø½ÃŰ´Â Àü¾Ð.
  • excitatory synapse
    ÈïºÐ¼º ½Ã³³½º
  • A delta pain fiber
    A µ¨Å¸ µ¿Åë ½Å°æ ¼¶À¯, A µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
  • A-beta fiber
    A-º£Å¸ ½Å°æ ¼¶À¯
    Á¢ÃË, ¾Ð·Â ÀÚ±ØÀ» Àü´ÞÇÏ´Â À¯¼ö ½Å°æÀÌ´Ù.
  • a-delta pain fiber
    a-µ¨Å¸ ÅëÁõ ½Å°æ ¼¶À¯
    Á÷°æÀÌ 1-4§­ÀÎ ÅëÁõ Àü´Þ ½Å°æ ¼¶À¯ÀÌ´Ù. ¿¹¸®ÇÑ ÅëÁõÀ» Àü´ÞÇϸç, ¼ø°£ÀûÀÎ ÅëÁõÀ» ºü¸£°Ô Àü´ÞÇÑ´Ù.
  • absorbable fiber
    Èí¼ö¼º ¼¶À¯
    Èí¼ö¸¦ Àß ÇÏ´Â ¼ºÁúÀ» °¡Áø ¼¶À¯.
  • adrenergic fiber
    ¾Æµå·¹³¯¸°¼º ¼¶À¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptors, presynaptic Neurotransmitter receptors located on or near presynaptic terminals or varicosities. Presynaptic receptors which bind transmitter molecules released by the terminal itself are termed autoreceptors.
(12 Dec 1998)
presynaptic <anatomy, physiology> Situated proximal to a synapse or occurring before the synapse is crossed.
(05 Mar 1998)
presynaptic cell <physiology> In a chemical synapse, the cell that releases neurotransmitter that will stimulate the postsynaptic cell.
<neurology> In an electrically synapsed system, the cell that has the first action potential, but since synapses are rectifying, one of the two cells involved is always presynaptic.
(05 Mar 1998)
presynaptic membrane That part of the plasma membrane of an axon terminal that faces the plasma membrane of the neuron or muscle fibre with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon's plasma membrane.
See: synapse.
(05 Mar 2000)
presynaptic receptor <physiology> Receptors located on presynaptic terminals at synapses.
(05 Mar 1998)
presynaptic terminals The distal terminations of axons which are specialised for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.
(12 Dec 1998)
central excitatory state The building up of excitatory influences produced by individual impulses finally causes firing of the next neuron.
(05 Mar 2000)
excitatory Tending to produce excitation.
(05 Mar 2000)
excitatory amino acid <biochemistry> The naturally occurring amino acids L glutamate and L aspartate and their synthetic analogues, notably kainate, quisqualate and NMDA. They have the properties of excitatory neurotransmitters in the CNS, may be involved in long-term potentiation and can act as excitotoxins.
at least three classes of EAA receptor have been identified, the agonists of the N type receptor are L aspartate, NMDA and ibotenate, the agonists of the Q type receptor are L glutamate and quisqualate, agonists of the K type are L glutamate and kainate. All three receptor types are found widely in the CNS and particularly the telencephalon, N and Q type receptors tend to occur together and may interact, their distribution is complementary to the K type receptors. The ion fluxes through the Q and K receptors are relatively brief, whereas the flux through the N type is longer and carries a significant amount of calcium. Additionally the N type receptor is blockaded by magnesium near the resting potential and thus shows voltage gated ion channel properties, leading to a regenerative response, this is why N type receptors have been linked to long-term potentiation.
Invertebrate glutamate receptors may not have the same properties as those described above.
(18 Nov 1997)
excitatory amino acid agents Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neurons using excitatory amino acids.
(12 Dec 1998)
excitatory amino acid agonists Drugs that bind to and activate excitatory amino acid receptors.
(12 Dec 1998)
excitatory amino acid antagonists Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists.
(12 Dec 1998)
excitatory amino acids Endogenous amino acids released by neurons as excitatory neurotransmitters. Glutamic acid is the most common excitatory neurotransmitter in the brain. Aspartic acid has been regarded as an excitatory transmitter for many years, but the extent of its role as a transmitter is unclear.
(12 Dec 1998)
excitatory junction potential Discrete partial depolarisation of smooth muscle produced by stimulation of excitatory nerves; similar to small end-plate potentials. They summate with repeated stimuli.
(05 Mar 2000)
excitatory postsynaptic potential The change in potential which is produced in the membrane of the next neuron when an impulse which has an excitatory influence arrives at the synapse; it is a local change in the direction of depolarisation; summation of these potential's can lead to discharge of an impulse by the neuron.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excitatory
    ÈïºÐÇÏ´Â
  • fiber
    ¼¶À¯
  • acrylic fiber
    ¾ÆÅ©¸±¼¶À¯
  • carbon fiber
    ź¼Ò ¼¶À¯
  • dietary fiber
    À½½Ä ¼¶À¯
  • fiber
    ¼¶À¯Áú;´Ü¼¶À¯;¼º°Ý;¼ö¿°»Ñ¸®
  • fiber art
    ÆÄÀ̹ö¾ÆÆ®
  • fiber optics
    ¼¶À¯ ±¤ÇÐ(À¯¸®³ª ÇÃ¶ó½ºÆ½ ¼¶À¯°üÀ» ÅëÇÏ¿© ±¤»óÀ» ±¼Àý½ÃÄÑ Àü´ÞÇÏ´Â ±â¼ú)
  • glass fiber(fibre)
    À¯¸® ¼¶À¯
  • graphite fiber
    ±×·¡ÆÄÀÌÆ® ÆÄÀ̹ö(¼¶À¯)
  • nerve fiber
    ½Å°æ¼¶À¯
  • staple fiber
    Àΰß;½ºÇÁ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á